Ripple Software Achieves 96% Clinical Trial Retention
Share Article
Ripple Science Logo ANN ARBOR, Mich. (PRWEB) May 10, 2021 A white paper recently published by Ripple Science revealed that its flagship product, Ripple, empowered its customers to achieve >96% retention across all trials and 99% retention in 78.2% of completed trials, far outpacing industry averages.
Ripple Science is the leading provider of clinical trial software used by sites, CROs, and study sponsors to assist and automate the patient engagement workflow end-to-end, from first contact to study completion. Ripple has supported over 700 clinical trials involving over 240,000 patients globally, including a large number of Alzheimer s, dementia, and CNS trials where patient engagement is particularly challenging.
Corticosteroids not recommended to treat smell loss due to Covid-19, study shows
Apr 27 2021
Steroids should not be used to treat smell loss caused by Covid-19 according to an international group of smell experts, including Prof Carl Philpott from the University of East Anglia.
Image Credit: University of East Anglia
Smell loss is a prominent symptom of Covid-19, and the pandemic is leaving many people with long-term smell loss.
But a new study published today shows that corticosteroids - a class of drug that lowers inflammation in the body – are not recommended to treat smell loss due to Covid-19.
Instead, the team recommend ‘smell training’ – a process that involves sniffing at least four different odors twice a day for several months.
E-Mail
Steroids should not be used to treat smell loss caused by Covid-19 according to an international group of smell experts, including Prof Carl Philpott from the University of East Anglia.
Smell loss is a prominent symptom of Covid-19, and the pandemic is leaving many people with long-term smell loss.
But a new study published today shows that corticosteroids - a class of drug that lowers inflammation in the body - are not recommended to treat smell loss due to Covid-19.
Instead, the team recommend smell training - a process that involves sniffing at least four different odours twice a day for several months.
Press release content from Business Wire. The AP news staff was not involved in its creation.
VERDE ANNOUNCES CHAIRMAN, INDEPENDENT LEAD DIRECTOR AND COMPOSITION OF BOARD COMMITTEES
April 7, 2021 GMT
Verde AgriTech Plc (TSX: “NPK”) (OTCQB: “AMHPF”) (”
Verde ” or the “
Company ”) is pleased to announce that Cristiano Veloso has been appointed Chairman of the Board of Directors (the “
Board ”) and that Michael St Aldwyn has been appointed Lead Independent Director of the Board.
Mr. Veloso, Verde’s Founder, President and Chief Executive Officer, will serve as the Chairman of the Board. The Board is composed of five independent directors and Mr. Veloso as sole executive director. The position of Chairman had been vacant since December 2013.
Ripple Science Named Top 50 Companies to Watch in 2021 by Michigan Celebrates Small Businesses
Share Article
Ripple Science is being recognized as one of the 2021 awardees for the Michigan 50 Companies to Watch award, presented by Michigan Celebrates Small Business. ANN ARBOR, Mich. (PRWEB) April 07, 2021 Ripple Science is being recognized as one of the 2021 awardees for the Michigan 50 Companies to Watch award, presented by Michigan Celebrates Small Business. Ripple Science will be honored at an awards ceremony during the 17th annual Michigan Celebrates Small Business gala event, July 20.
Ripple Science is an emerging innovative Saas and fast growing eClinical company dedicated to accelerating clinical trials through improved patient recruitment and retention. By adapting marketing and sales automation techniques to patient engagement Ripple speeds the enrollment process while reducing participant drop out rate